Exploitation of acoustic cavitation-induced microstreaming to enhance molecular transport

Journal of Pharmaceutical Sciences

Volumn 103, Issue 6, 2014, Pages 1903-1912

  Bhatnagar, Sunali ^a   Schiffter, Heiko ^a   Coussios, Constantin C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

acoustic cavitation; facilitated diffusion transport; fluorescence spectroscopy; microscopy; transdermal; ultrasound

Indexed keywords

VACCINE;

ACOUSTIC CAVITATION; ACTIVE TRANSPORT; ARTICLE; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; HUMAN; IN VITRO STUDY; MOLECULAR SIZE; MOLECULAR WEIGHT; NONHUMAN; RADIATION EXPOSURE; ULTRASOUND; ACOUSTICS;

ACOUSTICS; DRUG DELIVERY SYSTEMS; ULTRASONICS;

EID: 84901263900     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23971     Document Type: Article

References (39)

1. Saia MH, Sharman F, Abiteboul J, Campins D, Burkowitz M, Choe J, Kavanagh YS,. 2013. Needlestick injuries: Incidence and cost in the United States, United Kingdom, Germany, France, Italy, and Spain. Biomed Int 1 (1): 41-49.
2. Giudice EL, Campbell JD,. 2006. Needle-free vaccine delivery. Adv Drug Del Rev 58 (1): 68-89.
3. Mitragotri S, Kost J,. 2001. Transdermal delivery of heparin and low-molecular weight heparin using low-frequency ultrasound. Pharm Res 18 (8): 1151-1156.
4. Mathias NR, Hussain MA,. 2010. Non-invasive systemic drug delivery: Developability considerations for alternate routes of administration. J Pharm Sci 99 (1): 1-20.
5. Williams AC, Barry BW,. 2004. Penetration enhancers. Adv Drug Deliv Rev 56 (5): 603-618.
6. Schuetz YB, Naik A, Guy RH, Kalia YN,. 2005. Emerging strategies for the transdermal delivery of peptide and protein drugs Expert Opin Drug Deliv 2:533-548.
7. Kalia YN, Naik A, Garrison J, Guy RH,. 2004. Iontophoretic drug delivery. Adv Drug Deliv Rev 56 (5): 619-658.
8. Alvarez-Román R, Merino G, Kalia Y, Naik A, Guy R,. 2003. Skin permeability enhancement by low frequency sonophoresis: Lipid extraction and transport pathways. J Pharm Sci 92 (6): 1138-1146.
9. Benson HAE, McElnay JC, Harland R,. 1989. Use of ultrasound to enhance percutaneous absorption of benzydamine. Phys Ther 69: 113-118.
10. Dahlan A, Alpar HO, Stickings P, Sesardic D, Murdan S,. 2009. Transcutaneous immunisation assisted by low-frequency ultrasound. Int J Pharm 368 (1-2): 123-128.
11. Polat BE, Hart D, Langer R, Blankschtein D,. 2011. Ultrasound-mediated transdermal drug delivery: Mechanisms, scope, and emerging trends. J Control Release 152: 330-348.
12. Coussios CC, Farny C, Ter Haar G, Roy R,. 2007. Role of acoustic cavitation in the delivery and monitoring of cancer treatment by high-intensity focused ultrasound (HIFU). Int J Hyperthermia 23 (2): 105-120.
13. Mitragotri S, Kost J,. 2004. Low-frequency sonophoresis: A review. Adv Drug Deliv Rev 56 (5): 589-601.
14. Gyongy M, Coussios CC,. 2010. Passive spatial mapping of inertial cavitation during HIFU exposure. IEEE Trans Biomed Eng 57 (1): 48-56.
15. Coussios CC, Roy RA,. 2008. Applications of acoustics and cavitation to noninvasive therapy and drug delivery. Annu Rev Fluid Mech 40: 395-420.
16. Torr G., 1984. The acoustic radiation force. Am J Phys 52: 402.
17. Frenkel V, Gurka R, Liberzon A, Shavit U, Kimmel E,. 2001. Preliminary investigations of ultrasound-induced acoustic streaming using particle image velocimetry. Ultrasonics 39 (3): 153-156.
18. Mitragotri S, Kost J,. 2000. Low-frequency sonophoresis: A noninvasive method of drug delivery and diagnostics. Biotechnol Prog 16 (3): 488-492.
19. Kim D, Choi S, Kwak Y,. 2012. The effect of SonoPrep® on EMLA® cream application for pain relief prior to intravenous cannulation. Eur J Pediatr 171 (6): 985-988.
20. Polat BE, Figueroa PL, Blankschtein D, Langer R,. 2011. Transport pathways and enhancement mechanisms within localized and non-localized transport regions in skin treated with low-frequency sonophoresis and sodium lauryl sulfate. J Pharm Sci 100 (2): 512-529.
21. Mitragotri S, Ray D, Farrell J, Tang H, Yu B, Kost J, Blankschtein D, Langer R,. 2000. Synergistic effect of low-frequency ultrasound and sodium lauryl sulfate on transdermal transport. J Pharm Sci 89 (7): 892-900.
22. Boucaud A, Montharu J, Machet L, Arbeille B, Machet MC, Patat F, Vaillant L,. 2001. Clinical, histologic, and electron microscopy study of skin exposed to low-frequency ultrasound. Anat Rec 264 (1): 114-119.
23. Prausnitz MR, Langer R,. 2008. Transdermal drug delivery. Nat Biotechnol 26 (11): 1261-1268.
24. Chen X, Peng L-H, Shan Y-H, Li N, Wei W, Yu L, Li Q-M, Liang W-Q, Gao J-Q,. 2013. Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery. Int J Pharm 447 (1-2): 171-181.
25. Holt RG, Roy RA,. 2001. Measurements of bubble-enhanced heating from focused, MHz-frequency ultrasound in a tissue-mimicking material. Ultrasound Med Biol 27 (10): 1399-1412.
26. Pernodet N, Maaloum M, Tinland B,. 1997. Pore size of agarose gels by atomic force microscopy. Electrophoresis 18 (1): 55-58.
27. Aguilella V, Kontturi K, Murtomäki L, Ramírez P,. 1994. Estimation of the pore size and charge density in human cadaver skin. J Control Release 32 (3): 249-257.
28. Nandlall SD,. 2011. Monitoring cell and tissue damage during ablation by high-intensity focussed ultrasound. Oxford, UK: Department of Engineering Science, St Anne's College, University of Oxford.
29. Hockham N, Coussios CC, Arora M,. 2010. A real-time controller for sustaining thermally relevant acoustic cavitation during ultrasound therapy. IEEE Trans Biomed Eng Ultrason Ferroelectr Freq Control 57 (12): 2685-2694.
30. Mylonopoulou E, Bazán-Peregrino M, Arvanitis CD, Coussios CC,. 2013. A non-exothermic cell-embedding tissue-mimicking material for studies of ultrasound-induced hyperthermia and drug release. Int J Hyperthermia 29 (2): 133-144.
31. Jaiswal JK, Simon SM,. 2004. Potentials and pitfalls of fluorescent quantum dots for biological imaging. Trends Cell Biol 14 (9): 497-504.
32. Paliwal S, Menon GK, Mitragotri S,. 2006. Low-frequency sonophoresis: Ultrastructural basis for stratum corneum permeability assessed using quantum dots. J Invest Dermatol 126 (5): 1095-1101.
33. Maoquan C, Qiang W, Jiaxu W, Shengke H, Yi M, Jinliang P, Ye S,. 2007. In vitro and in vivo transdermal delivery capacity of quantum dots through mouse skin. Nanotechnology 18 (45): 455103.
34. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA,. 2006. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 91 (1): 159-165.
35. Abernathy VJ, Pou NA, Wilson TL, Parker RE, Mason SN, Clanton JA, Baundendistel LJ, Roselli RJ,. 1995. Noninvasive measures of radiolabeled dextran transport in in situ rabbit lung. J Nucl Med 36: 1436-1436.
36. Kushner Jt, Blankschtein D, Langer R,. 2007. Evaluation of the porosity, the tortuosity, and the hindrance factor for the transdermal delivery of hydrophilic permeants in the context of the aqueous pore pathway hypothesis using dual-radiolabeled permeability experiments. J Pharm Sci 96 (12): 3263-3282.
37. Chen D, Kristensen D,. 2009. Opportunities and challenges of developing thermostable vaccines. Expert Rev Vaccines 8 (5): 547-557.
38. Tezel A, Paliwal S, Shen Z, Mitragotri S,. 2005. Low-frequency ultrasound as a transcutaneous immunization adjuvant. Vaccine 23 (29): 3800-3807.
39. Bazan-Peregrino M, Arvanitis CD, Rifai B, Seymour LW, Coussios C-C,. 2012. Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model. J Control Release 157 (2): 235-242.